Gout lessons from 2018: CARES, a direct comparison of febuxostat vs allopurinol, and CANTOS, IL1 blocker for cardiovascular risk minimisation
Crossref DOI link: https://doi.org/10.1007/s10067-018-4396-4
Published Online: 2018-12-12
Published Print: 2019-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jansen, Tim L. Th. A. http://orcid.org/0000-0003-3026-3154
Janssen, Matthijs
Text and Data Mining valid from 2018-12-12
Article History
Received: 29 November 2018
Accepted: 4 December 2018
First Online: 12 December 2018
Compliance with ethical standards
:
: None.